KTRA insider filings
Kintara Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-10-22. Screen KTRA transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for KTRA between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Kintara Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-10-22 | 4 | Yamashita Dennis — Chief Scientific Officer | Grant/award (A): 196,790 (derivative) @ $0 | EDGAR |
| 2024-10-22 | 4 | Ng George K — Director | Grant/award (A): 35,780 (derivative) @ $0 · Grant/award (A): 13,553 (derivative) @ $0 · Grant/award (A): 13,553 (derivative) @ $0 | EDGAR |
| 2024-10-22 | 4 | List Alan — Director | Grant/award (A): 13,553 (derivative) @ $0 · Grant/award (A): 13,553 (derivative) @ $0 | EDGAR |
| 2024-10-22 | 4 | Dearborn Dan — Chief Financial Officer | Grant/award (A): 33,991 (derivative) @ $0 · Grant/award (A): 68,438 (derivative) @ $0 · Grant/award (A): 232,570 (derivative) @ $0 · Grant/award (A): 15,744 (derivative) @ $0 · Grant/award (A): 66,658 (derivative) @ $0 | EDGAR |
| 2024-10-22 | 4 | MANUSO JAMES S J — Director | Grant/award (A): 13,553 (derivative) @ $0 · Grant/award (A): 13,553 (derivative) @ $0 | EDGAR |
| 2024-10-22 | 4 | Bianco James A. — Chief Executive Officer, Director | Grant/award (A): 2,323,307 @ $0 · Grant/award (A): 357,800 (derivative) @ $0 · Grant/award (A): 71,560 (derivative) @ $0 · Grant/award (A): 191,280 (derivative) @ $0 | EDGAR |
| 2023-09-01 | 4 | Johnson Laura L. — Director | Grant/award (A): 8,500 (derivative) @ $0 | EDGAR |
| 2023-09-01 | 4 | TOTH ROBERT JOSEPH JR — Director | Grant/award (A): 8,500 (derivative) @ $0 | EDGAR |
| 2023-09-01 | 4 | Brown Dennis M — Chief Scientific Officer | Grant/award (A): 10,175 (derivative) @ $0 | EDGAR |
| 2023-09-01 | 4 | FAVORITO TAMARA A — Director | Grant/award (A): 8,500 (derivative) @ $0 | EDGAR |
| 2023-09-01 | 4 | Hoffman Robert E. — President, CEO and Interim CFO, Director | Grant/award (A): 23,142 (derivative) @ $0 | EDGAR |
| 2023-06-02 | 4 | Hoffman Robert E. — President, CEO, and CFO, Director | Grant/award (A): 59,800 @ $0 | EDGAR |
| 2023-01-06 | 4 | Brown Dennis M — Chief Scientific Officer | Code (W): 363 @ $0 | EDGAR |
| 2022-08-03 | 4 | Brown Dennis M — Chief Scientific Officer | Grant/award (A): 240,087 @ $0 · Grant/award (A): 720,260 (derivative) @ $0 | EDGAR |
| 2022-08-03 | 4 | Praill Anthony Scott — Chief Financial Officer | Grant/award (A): 240,087 @ $0 · Grant/award (A): 720,260 (derivative) @ $0 | EDGAR |
| 2022-08-03 | 4 | Hoffman Robert E. — President and CEO, Director | Grant/award (A): 400,145 @ $0 · Grant/award (A): 1,200,634 (derivative) @ $0 | EDGAR |
| 2022-07-05 | 4 | TOTH ROBERT JOSEPH JR — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-07-05 | 4 | Johnson Laura L. — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-07-05 | 4 | SEYMOUR TAMARA A — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-02-17 | 4 | Hoffman Robert E. — President and CEO, Director | Purchase (P): 55,000 @ $0.47 | EDGAR |
| 2021-12-09 | 4 | Praill Anthony Scott — Chief Financial Officer | Purchase (P): 28,700 @ $0.68 | EDGAR |
| 2021-12-08 | 4 | Zarrabian Saiid — Head of Strategic Partnerships, Director | Purchase (P): 11,891 @ $0.59 · Purchase (P): 38,109 @ $0.64 | EDGAR |
| 2021-11-24 | 4 | Johnson Laura L. — Director | Purchase (P): 3,000 @ $0.74 | EDGAR |
| 2021-11-10 | 4 | HOFFMAN ROBERT — President and CEO, Director | Grant/award (A): 3,519,170 (derivative) @ $0 | EDGAR |
| 2021-09-22 | 4 | Murphy Keith — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2021-09-22 | 4 | TOTH ROBERT JOSEPH JR — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2021-09-22 | 4 | Johnson Laura L. — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2021-09-22 | 4 | SEYMOUR TAMARA A — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2021-09-22 | 4 | HOFFMAN ROBERT — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2021-05-03 | 4 | SEYMOUR TAMARA A — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2021-04-29 | 4 | Brown Dennis M — Chief Scientific Officer | Other (J): 6 @ $0 · Conversion (C): 750 · Conversion (C): 3,000 (derivative) @ $0 | EDGAR |
| 2021-04-29 | 4 | TOTH ROBERT JOSEPH JR — Director | Other (J): 3 @ $0 · Conversion (C): 325 · Conversion (C): 1,300 (derivative) @ $0 | EDGAR |
| 2021-04-29 | 4 | Praill Anthony Scott — Chief Financial Officer | Other (J): 8 @ $0 · Conversion (C): 938 · Conversion (C): 3,750 (derivative) @ $0 | EDGAR |
| 2021-03-31 | 4 | TOTH ROBERT JOSEPH JR — Director | Other (J): 8 @ $0 | EDGAR |
| 2021-03-31 | 4 | Brown Dennis M — Chief Scientific Officer | Other (J): 17 @ $0 | EDGAR |
| 2021-03-31 | 4 | Praill Anthony Scott — Chief Financial Officer | Other (J): 22 @ $0 | EDGAR |
| 2021-01-04 | 4 | TOTH ROBERT JOSEPH JR — Director | Other (J): 8 @ $0 | EDGAR |
| 2021-01-04 | 4 | Brown Dennis M — Chief Scientific Officer | Other (J): 17 @ $0 | EDGAR |
| 2021-01-04 | 4 | Praill Anthony Scott — Chief Financial Officer | Other (J): 22 @ $0 | EDGAR |
| 2020-09-30 | 4 | TOTH ROBERT JOSEPH JR — Director | Other (J): 8 @ $0 | EDGAR |
| 2020-09-30 | 4 | Brown Dennis M — Chief Scientific Officer | Other (J): 17 @ $0 | EDGAR |
| 2020-09-30 | 4 | Praill Anthony Scott — Chief Financial Officer | Other (J): 22 @ $0 | EDGAR |
| 2020-09-24 | 4 | Brown Dennis M — Chief Scientifc Officer | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2020-09-24 | 4/A | Brown Dennis M — Chief Scientific Officer | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2020-09-17 | 4 | TOTH ROBERT JOSEPH JR — Director | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2020-09-17 | 4 | Murphy Keith — Director | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2020-09-17 | 4 | Johnson Laura L. — Director | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2020-09-17 | 4 | Zarrabian Saiid — President and CEO, Director | Grant/award (A): 2,715,004 (derivative) @ $0 | EDGAR |
| 2020-09-17 | 4 | Praill Anthony Scott — Chief Financial Officer | Grant/award (A): 606,557 (derivative) @ $0 | EDGAR |
| 2020-09-17 | 4 | HOFFMAN ROBERT — Director | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Kintara Therapeutics, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-18 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-06 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-16 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-24 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-17 | 8-K/A | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-17 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-16 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-04 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-21 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=KTRA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs